Concord Medical Schedules 2024 Annual Meeting of Shareholders
Concord Medical Services Holdings (NYSE: CCM) announced its 2024 annual general meeting of shareholders, scheduled for December 27, 2024, at 10:00 a.m. (Beijing Time) in Beijing, China. The meeting's primary purpose is to amend the company's memorandum and articles of association to reflect changes in the ratio of American depositary shares (ADSs) to Class A ordinary shares, effective July 30, 2024. Shareholders of record as of November 27, 2024, will be eligible to attend and discuss company affairs with management.
Concord Medical Services Holdings (NYSE: CCM) ha annunciato la sua riunione annuale degli azionisti del 2024, programmata per il 27 dicembre 2024, alle 10:00 (ora di Pechino) a Pechino, Cina. Lo scopo principale della riunione è quello di modificare il memorandum e gli articoli di associazione della società per riflettere le modifiche nel rapporto tra le azioni di deposito americane (ADS) e le azioni ordinarie di Classe A, a partire dal 30 luglio 2024. Gli azionisti registrati al 27 novembre 2024 potranno partecipare e discutere le questioni aziendali con il management.
Concord Medical Services Holdings (NYSE: CCM) anunció su reunión anual de accionistas para 2024, programada para el 27 de diciembre de 2024, a las 10:00 a.m. (hora de Pekín) en Pekín, China. El principal propósito de la reunión es enmendar el memorándum y los artículos de asociación de la empresa para reflejar los cambios en la relación entre las acciones de depósito americanas (ADS) y las acciones ordinarias de Clase A, con efecto a partir del 30 de julio de 2024. Los accionistas registrados al 27 de noviembre de 2024, serán elegibles para asistir y discutir los asuntos de la empresa con la dirección.
콘코드 메디컬 서비스 홀딩스 (NYSE: CCM)는 2024년 주주 총회를 2024년 12월 27일 오전 10시(베이징 시간) 중국 베이징에서 개최한다고 발표했습니다. 회의의 주요 목적은 2024년 7월 30일부터 시행되는 미국 예탁주식(ADS)과 A급 보통주 간의 비율 변경을 반영하기 위해 회사의 정관 및 운영규정을 수정하는 것입니다. 2024년 11월 27일자로 주주로 등록된 이들은 경영진과 함께 회사의 사안에 대해 참석하고 논의할 수 있습니다.
Concord Medical Services Holdings (NYSE: CCM) a annoncé la tenue de son assemblée générale annuelle des actionnaires pour 2024, prévue le 27 décembre 2024 à 10h00 (heure de Pékin) à Pékin, en Chine. Le principal objectif de cette réunion est de modifier le mémorandum et les articles de l'association de la société afin de refléter les changements dans le rapport entre les actions de dépôt américaines (ADS) et les actions ordinaires de classe A, effectif à compter du 30 juillet 2024. Les actionnaires inscrits au 27 novembre 2024 auront le droit d'assister à la réunion et de discuter des affaires de l'entreprise avec la direction.
Concord Medical Services Holdings (NYSE: CCM) hat die jährliche Hauptversammlung der Aktionäre für 2024 angekündigt, die für den 27. Dezember 2024 um 10:00 Uhr (Peking-Zeit) in Peking, China, geplant ist. Das Hauptziel der Versammlung besteht darin, das Gesellschaftsstatut und die Satzung des Unternehmens zu ändern, um die Änderungen im Verhältnis von American Depositary Shares (ADS) zu den A-Klasse Stammaktien zu reflektieren, wirksam ab dem 30. Juli 2024. Aktionäre, die am 27. November 2024 im Aktienregister eingetragen sind, sind berechtigt, an der Versammlung teilzunehmen und Unternehmensangelegenheiten mit der Geschäftsführung zu besprechen.
- None.
- None.
The purpose of the Meeting is to amend the Company's memorandum and articles of association currently in effect by the adoption of a new memorandum and articles of association to reflect the change in the ratio of its American depositary shares ("ADSs") to Class A ordinary shares, which was made effective on July 30, 2024. For details, please refer to the Current Report on Form 6-K filed with the Securities and Exchange Commission ("SEC") on July 11, 2024. The Meeting will also be convened for shareholders who are entitled to vote to discuss Company affairs with management. Concord Medical's annual report on Form 20-F filed with the SEC, containing the Company's audited financial statements for the financial year ended December 31, 2023, is available in the Investor Relations section of the Company's website at http://ir.ccm.cn. The Form 20-F is also available on the SEC's website at http://www.sec.gov.
About Concord Medical
Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across
Safe Harbor Statement
This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
View original content:https://www.prnewswire.com/news-releases/concord-medical-schedules-2024-annual-meeting-of-shareholders-302303811.html
SOURCE Concord Medical Services Holdings Limited
FAQ
When is Concord Medical's (CCM) 2024 annual shareholders meeting?
What is the record date for CCM's 2024 annual meeting?
What is the main purpose of CCM's 2024 annual meeting?
Where will CCM's 2024 annual meeting be held?
